Skip to main content
Toggle navigation
Search
Home
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Presentation Icons
Red Recording
Sig Meeting
Like
Tweet
Print
Janette Contreras-De Lama, PhD
AbbVie
Poster(s):
(T 11) Effect of Adding Atogepant to OnabotulinumtoxinA on Symptoms-Free Days: Results from a Phase 3, Multicenter, 24-Week Open-Label Study (UNCHAINED)
(T 14) Characterizing Menstrual Migraine: Multi-Country Results from the Chronic Migraine Epidemiology and Outcomes-International (CaMEO-I) Study